#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Short-bowel syndrome Chronic myelomonocytic leukaemia Immunodeficiency congenital Prostate cancer Adult T-cell lymphoma/leukaemia refractory Fabry's disease Langerhans cell sarcoma Ovarian cancer stage IV Myxoid liposarcoma Postprandial hypoglycaemia Erdheim-Chester disease Non-Hodgkin's lymphoma unspecified histology indolent Encephalitis autoimmune Retinoblastoma Oesophageal squamous cell carcinoma stage III More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Life with Disease Krabbe’s disease – Life with Disease Hereditary angioedema – Diagnostics Glycogen storage disease type I – Trials in Disease Friedreich’s ataxia – Life with Disease Adrenogenital syndrome – Basic Information Hereditary hypophosphataemic rickets – Trials in Disease Glomerulonephritis membranous – Diagnostics Medulloblastoma – Basic Information Progressive supranuclear palsy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glpg3667 Fumarate Esketamine Eptinezumab Fluticasone Sarilumab SULBACTAM SODIUM Df6002 Doxycycline Monohydrate Neostigmine Methylsulfate Sotagliflozin Xevinapant Enfortumab Vedotin Immunoglobulin A Pentetic Acid Sargramostim For-6219 D-Biotin Atuliflapon Gskvx000000017033 Tuvusertib More therapies…

    Learn about Your Condition

    Pancreatic carcinoma Oesophagogastroscopy Ependymoma malignant Dystonic tremor Depression Langerhans cell sarcoma Oxygen saturation Tuberous sclerosis complex Obsessive-compulsive disorder Malignant fibrous histiocytoma Eructation Mitral valve disease Embolism Abortion threatened Connective tissue disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study testing omaveloxolone compared to placebo for children and adolescents aged 2 to 15 years with Friedreich’s ataxia

    Recruiting

    3 1
    Investigated Drugs:
    • Omaveloxolone
    Austria Denmark France Germany Ireland Italy +2

  • A Study of Tulisokibart for Adults with Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)

    Recruiting

    2 1
    Investigated Diseases:
    • Ankylosing spondylitis
    Investigated Drugs:
    • Tulisokibart
    Germany The Netherlands Poland

  • Study of Lisocabtagene Maraleucel as First Treatment for Adults with Primary Central Nervous System Lymphoma Who Cannot Have a Stem Cell Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Central nervous system lymphoma
    Investigated Drugs:
    • Procarbazine
    • Lisocabtagene Maraleucel
    • Calcium Folinate
    France Germany

  • A Study Testing Prolonged versus Single Dose Penicillin Challenge in Patients with Suspected Penicillin Allergy Using Amoxicillin

    Recruiting

    3 1
    Investigated Diseases:
    • Hypersensitivity
    Investigated Drugs:
    • Amoxicillin Trihydrate
    Belgium Denmark

  • Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    • Colorectal cancer stage II
    • Colorectal cancer stage III
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    Spain

  • A study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Czechia France Hungary Italy Poland
Previous Page
1 … 114 115 116 117 118 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!